Clinical trial
Study of Recombinant Human Thrombin for Bleeding During Surgery
NCT00245336 · ZymoGenetics, Industry · Completed
Key facts
| NCT number | NCT00245336 |
|---|---|
| Title | Study of Recombinant Human Thrombin for Bleeding During Surgery |
| Official title | A Phase 3, Randomized, Double-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Recombinant Human Thrombin (rhThrombin) and Thrombin-JMI (Bovine Thrombin) in Surgical Hemostasis |
| Lead sponsor | ZymoGenetics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Surgical Hemostasis |
| Intervention type | Biological, Drug |
| Interventions | rThrombin, bovine thrombin |
| Enrollment | 401 |
| Start date | Oct 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Oct 27, 2005 |
| Last update posted | Mar 9, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: